Global Regenerative Medicine Market Size & Outlook
The regenerative medicine industry worldwide is expected to reach a projected revenue of US$ 90,013.8 million by 2030. A compound annual growth rate of 16.8% is expected of the worldwide regenerative medicine industry from 2024 to 2030.
Revenue, 2023 (US$M)
$30,437.3
Forecast, 2030 (US$M)
$90,013.8
CAGR, 2024 - 2030
16.8%
Report Coverage
Worldwide
Global regenerative medicine market, 2018-2030 (US$M)
Related Markets
Global regenerative medicine market highlights
- The global regenerative medicine market generated a revenue of USD 30,437.3 million in 2023 and is expected to reach USD 90,013.8 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 16.8% by 2030.
- In terms of segment, therapeutics accounted for a revenue of USD 23,206.5 million in 2023.
- Banks is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 30,437.3 million |
| Market revenue in 2030 | USD 90,013.8 million |
| Growth rate | 16.8% (CAGR from 2023 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Banks |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Therapeutics, Tools, Banks, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 58.4% of the global regenerative medicine market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 6.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Regenerative Medicine Market Scope
Regenerative medicine market segmentation & scope
Others
Others
Others
Regenerative Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global regenerative medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regenerative medicine market will help companies and investors design strategic landscapes.
therapeutics was the largest segment with a revenue share of 76.24% in 2023. Horizon Databook has segmented the Global regenerative medicine market based on therapeutics, tools, banks, services covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Regenerative Medicine Product Outlook (Revenue, USD Million, 2018-2030)
- Therapeutics
- Primary cell-based therapeutics
- Dermatology
- Musculoskeletal
- Surgical
- Dental
- Others
- Stem Cell & Progenitor Cell-based therapeutics
- Autologous
- Allogenic
- Others
- Cell-based Immunotherapies
- Gene Therapies
- Primary cell-based therapeutics
- Tools
- Banks
- Services
- Therapeutics
- Global Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2018-2030)
- Dermatology
- Musculoskeletal
- Immunology & Inflammation
- Oncology
- Cardiovascular
- Ophthalmology
- Others
Reasons to subscribe to Global regenerative medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global regenerative medicine market databook
-
Our clientele includes a mix of regenerative medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global regenerative medicine market , including forecasts for subscribers. This global databook contains high-level insights into Global regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global regenerative medicine market statistics, by region, 2018-2030 (US$M)
Top 10 countries: Regenerative medicine market size, 2023 (USD Million)
Top 10 countries: Regenerative medicine market size, 2023 (USD Million)
Global regenerative medicine market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
